1. Home
  2. VIVS vs NXGL Comparison

VIVS vs NXGL Comparison

Compare VIVS & NXGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo VivoSim Labs Inc.

VIVS

VivoSim Labs Inc.

N/A

Current Price

$0.16

Market Cap

2.1M

Sector

Health Care

ML Signal

N/A

Logo NexGel Inc

NXGL

NexGel Inc

N/A

Current Price

$3.94

Market Cap

2.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
VIVS
NXGL
Founded
2007
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1M
2.0M
IPO Year
2010
2019

Fundamental Metrics

Financial Performance
Metric
VIVS
NXGL
Price
$0.16
$3.94
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 721.4K
594.9K
Earning Date
11-13-2026
11-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 24.00
EPS
★ N/A
N/A
Revenue
$4,603,000.00
★ $11,421,000.00
Revenue This Year
$228,144.28
$38.23
Revenue Next Year
N/A
$53.72
P/E Ratio
N/A
★ N/A
Revenue Growth
8.82
★ 31.46
52 Week Low
$0.14
$0.15
52 Week High
$3.40
$214.40

Technical Indicators

Market Signals
Indicator
VIVS
NXGL
Relative Strength Index (RSI) 37.34 41.19
Support Level N/A $3.12
Resistance Level $0.30 $7.25
Average True Range (ATR) 0.02 0.92
MACD 0.00 0.32
Stochastic Oscillator 36.23 15.75

Price Performance

Historical Comparison
VIVS
NXGL

About VIVS VivoSim Labs Inc.

VivoSim Labs Inc is a pharmaceutical and biotechnology services company focused on testing drugs and drug candidates in three-dimensional human tissue models of the liver and intestine. The Company provides liver and intestinal toxicology insights using its new approach methodologies and models and offers liver toxicology predictive screening and research services, as well as services to predict and study the intestinal side effect profiles of therapeutic candidates at all stages of drug development. Its 3D human tissue platform includes expertise in 3D organoids, such as spheroids, and proprietary cell culture techniques.

About NXGL NexGel Inc

NexGel Inc manufactures high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company specializes in custom gels by capitalizing on proprietary manufacturing technologies. The gels and consumer products are manufactured using proprietary and non-proprietary mixing, coating and cross-linking technologies.

Share on Social Networks: